Evidence map›Paper›PMID 42909731›Full record

ArticleEJNMMI research2026

Automated PET tracer classification in multi-site, multi-cohort studies using deep learning.

Robel K Gebre, Robert I Reid, Matthew L Senjem, Jeffrey L Gunter, Val J Lowe, Kejal Kantarci, Ronald C Petersen, Jonathan Graff-Radford, Clifford R Jack, Prashanthi Vemuri and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robel K GebreAging and Dementia Imaging Research (ADIR), Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. gebre.robelkebede@mayo.edu.ORCID http://orcid.org/0000-0002-5746-0994
Robert I ReidDepartment of Information Technology, Mayo Clinic, Rochester, MN, 55905, USA.
Matthew L SenjemDepartment of Information Technology, Mayo Clinic, Rochester, MN, 55905, USA.
Jeffrey L GunterAging and Dementia Imaging Research (ADIR), Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Val J LoweDepartment of Nuclear Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Kejal KantarciAging and Dementia Imaging Research (ADIR), Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Clifford R JackAging and Dementia Imaging Research (ADIR), Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Prashanthi VemuriAging and Dementia Imaging Research (ADIR), Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Christopher G SchwarzAging and Dementia Imaging Research (ADIR), Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Alzheimer’s Disease Neuroimaging Initiative

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PANKRATZ, V. SHANE · 1999 to 2018
$36.9M
Longitudinal Imaging Biomarkers of Prodromal DLBU01NS100620 · NINDS · MAYO CLINIC ROCHESTER · PI Bradley F Boeve, KEJAL KANTARCI · 2017 to 2026
$19.2M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Investigating Resistance and Resilience Mechanisms in Alzheimer’s DiseaseR01AG056366 · NIA · MAYO CLINIC ROCHESTER · PI PRASHANTHI VEMURI · 2017 to 2026
$7.0M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
MarkVCID Validation in the General CommunityUF1NS125417 · NINDS · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C, VEMURI, PRASHANTHI · 2021 to 2023
$6.1M
Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRIR01AG068206 · NIA · MAYO CLINIC ROCHESTER · PI SCHWARZ, CHRISTOPHER GEORGE · 2021 to 2024
$3.2M
EXTRAMURAL RES FACIL IMPROVEMENT PROG: POLYCYSTIC KIDNEY DISEASE, RENAL STUDIES,C06RR018898 · NCRR · MAYO CLINIC · PI BURNETT, JOHN C · 2004 to 2004
$2.3M
Elsie and Marvin Dekelboum Family Foundation Elsie and Marvin Dekelboum Family FoundationGHR Foundation grant, the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation GHR Foundation grant, the Alexander Family Alzheimer's Disease Research Professorship of the Mayo FoundationNIA NIH HHS P50 AG016574NIA NIH HHS R01 AG034676NIA NIH HHS R01 AG056366NIA NIH HHS R01 AG068206NIA NIH HHS R37 AG011378NIA NIH HHS U01 AG006786NIA NIH HHS U01 NS100620NINDS NIH HHS UF1NS125417Opus building NIH grant C06 RR018898
6 · The paper itself

Abstract

backgroundRadiotracer labels in positron emission tomography (PET) DICOM metadata are manually entered and often unreliable or missing, requiring expert visual verification for downstream analyses. We developed and validated deep learning models to classify PET tracers directly from image data across multiple sites and cohorts.

resultsWe used PET scans obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI, n = 7429) and the Standardized Centralized Alzheimer's & Related Dementias Neuroimaging study (SCAN, n = 4869) to classify 10 tracers. We evaluated generalizability on an external test set of Mayo Clinic Study of Aging and ADRC scans containing four tracers (n = 10558). ADNI and SCAN data were combined and split into training (60%), validation (20%), and internal test (20%) sets. We trained two ConvNeXt-Large models initialized with ImageNet weights: a 10-class model (AV1451, FBP, FBP-Early, FBB, FBB-Early, FDG, MK6240, NAV4694, PI2620, PIB) and a 3-class model grouping tracers by biological target (Amyloid, FDG, Tau). Performance was evaluated using macro-F1, average precision (AP), and confusion matrices, Integrated Gradients for attribution, with Uniform Manifold Approximation and Projection (UMAP) and cosine similarity to assess model interpretability and multi-cohort effects on the embedding structure. The 3-class model achieved macro-F1 ≥ 0.99 across all test sets. The 10-class model achieved macro-F1 of 0.91 on the internal test and 0.93 on the external test set where only four tracers were available. Lower performance was observed for NAV4694 (AP 0.70; misclassified as FBB, 17.2%), PI2620 (0.79; AV1451, 20.0%), and FBB (0.80; FBP, 23.3%). The attribution maps indicated the models learned some tracer specific uptake patterns as well as general imaging features. Class embeddings in the UMAP projection showed clear separation, with limited overlap among underrepresented tracers with similar binding characteristics. Cohort-level differences in learned representations were most pronounced among tau tracers, with higher within-class cosine similarity in ADNI than in SCAN (mean [SD], 0.26 [0.10] vs. 0.01 [0.06]), while amyloid tracers showed minimal shift across cohorts.

conclusionsClassification was near-perfect when grouping tracers into three biological targets, and the 10-class model generalized well to the four tracers available in the independent external cohort. A few tracers with similar binding characteristics showed some overlap in latent space, with minimal impact on overall classification performance. Our results demonstrate that deep learning models can identify PET tracers from image appearance alone and have the potential to support semi-automated tracer identification and data curation in large multi-site PET studies.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.